The Discounted Cash Flow (DCF) valuation of Repligen Corp (RGEN) is 42.68 USD. With the latest stock price at 181.70 USD, the upside of Repligen Corp based on DCF is -76.5%.
Based on the latest price of 181.70 USD and our DCF valuation, Repligen Corp (RGEN) is a sell. selling RGEN stocks now will result in a potential gain of 76.5%.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 8.7% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 29.43 - 81.89 | 42.68 |
| Upside | -83.8% - -54.9% | -76.5% |